• HOME
  • ABOUT US
    • CAREERS
  • TECHNOLOGY
  • NEWS
  • SERVICES
    • RESEARCH AND DEVELOPMENT
  • PRODUCTS
    • My account
    • Cart
  • CONTACT
Type and hit ENTER
  • HOME
  • ABOUT US
    • CAREERS
  • TECHNOLOGY
  • NEWS
  • SERVICES
    • RESEARCH AND DEVELOPMENT
  • PRODUCTS
    • My account
    • Cart
  • CONTACT
GET CONNECTED
  • HOME
  • ABOUT US
    • CAREERS
  • TECHNOLOGY
  • NEWS
  • SERVICES
    • RESEARCH AND DEVELOPMENT
  • PRODUCTS
    • My account
    • Cart
  • CONTACT
ProAxsis team to attend BIO 2016
Share
Conferences, News

ProAxsis team to attend BIO 2016

June 2, 2016
-
Posted by Webmaster

ProAxsis will be attending the BIO 2016 conference, taking place at the Moscone Convention Center in San Francisco between June 5th-9th 2016.

The BIO International Convention attracts over 15,000 biotechnology and pharma leaders who come together for one week of intensive networking to discover new opportunities and promising partnerships. ProAxsis will be attending as part of the Invest Northern Ireland delegation, and will be represented at the meeting by Professor Brian Walker (Chief Scientific Officer) and Dr David Ribeiro (Chief Executive Officer).

Please visit us at the Invest NI stand, which can be found at booth 5858. Alternatively, any enquiries about our immunoassay for measuring neutrophil elastase as a biomarker for lung inflammation and infection, or any other aspects of the company’s proprietary ProteaseTag® technology, can be directed to info@proaxsis.com.

ProAxsis is part of the NetScientific group and is one of the group’s core portfolio companies. The company is also supported by QUBIS, the commercialisation arm of Queens University.

June 2, 2016

Related News

Other posts that you should not miss.
Announcements, News

NetScientific acquires 100% control of portfolio company ProAxsis Limited

October 16, 2020
-
Posted by David Ribeiro

ProAxsis Limited (www.proaxsis.com), the Belfast-based diagnostics company specialising in the measurement of active proteases and other inflammatory biomarkers, …

Read More
October 16, 2020
Posted by David Ribeiro
Conferences, NEATstik®

ProAxsis presenting new data at 2018 European Respiratory Society Conference

September 18, 2018
-
Posted by David Ribeiro

ProAxsis will today be presenting new data on its highly novel active neutrophil elastase (NE) point-of-care test, …

Read More
September 18, 2018
Posted by David Ribeiro
Announcements, News

ProAxsis and Ulster University initiate new partnership

June 29, 2020
-
Posted by David Ribeiro

ProAxsis (www.proaxsis.com), the Belfast-based diagnostics company, has formed a new partnership with Ulster University, the largest university …

Read More
June 29, 2020
Posted by David Ribeiro
← PREVIOUS POST
ProAxsis builds market presence
NEXT POST →
ProAxsis to present at 2016 American Thoracic Society Conference
Categories
  • Announcements
  • Conferences
  • NEATstik®
  • Neutrophil Elastase Immunoassay
  • News
  • ProteaseTag®
  • Trials
  • Video
GET CONNECTED
RECENT POSTS
  • ProAxsis Limited appoints first distributor for DACH region
    December 14, 2020

    ProAxsis Limited (www.proaxsis.com), the Belfast-based diagnostics company specialising in the measurement of active …

  • ProAxsis Limited supported by Innovate UK to accelerate work on inflammatory biomarkers associated with COVID-19
    December 10, 2020

    ProAxsis (www.proaxsis.com), the Belfast-based respiratory diagnostics company, today announces that it has been …

  • ProAxsis Limited recognised as Gold Level Innovator by Innovate NI
    December 2, 2020

    ProAxsis (www.proaxsis.com), the Belfast-based protease diagnostics company, is delighted to announce that it …


ProAxsis Ltd
Unit 1B, Concourse Building 3,
Catalyst Inc,
Queen’s Road, Titanic Quarter,
Belfast,
BT3 9DT,
Northern Ireland

tel +44 (0)28 9073 0444
email info@proaxsis.com

RECENT NEWS
  • February 21, 2021
    ProAxsis Limited enters licensing agreement with top Swiss University as it continues to develop novel new products in the fight against fractures and other metabolic bone diseases
  • December 14, 2020
    ProAxsis Limited appoints first distributor for DACH region
  • December 10, 2020
    ProAxsis Limited supported by Innovate UK to accelerate work on inflammatory biomarkers associated with COVID-19
LATEST TWEETS
Twitter
ProAxsis
Follow Me
ProAxsis is delighted to have received this support from Innovate UK - https://t.co/toTxOz9KK6
87 days ago
- ProAxsis
RT @GRobinsonDUP: I’m delighted that @ProAxsis based in East Belfast have been successful in their application for an Innovate UK Grant, wh…
87 days ago
- ProAxsis
We are delighted to announce that as of today, we have appointed an exclusive distributor for our portfolio of prod… https://t.co/rmCmIugsLa
108 days ago
- ProAxsis
Due to our continued expansion, we wish to recruit an Administration Officer. This post can be full-time or part-ti… https://t.co/k3wKwVfOKy
128 days ago
- ProAxsis
Copyright © 2016-2021 - ProAxsis - All rights reserved. 
ProAxsis team to attend BIO 2016 | ProAxsis